Product Development and Patent License Agreement between Abbott Biotherapeutics and Actinium Pharmaceuticals, Inc. (February 27, 2003)

This agreement is between Abbott Biotherapeutics and Actinium Pharmaceuticals, Inc. It outlines the terms under which Abbott grants Actinium rights to use certain patents for product development. Actinium is responsible for developing products using the licensed technology, and may owe payments or royalties to Abbott. The agreement specifies each party’s obligations, including development milestones and conditions for maintaining the license. It also covers how intellectual property is handled and any limitations or termination rights.